KBYPF (Kobayashi Pharmaceutical Co) Other Current Payables: $198 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KBYPF Kobayashi Pharmaceutical Co Ltd KBYPF
81 GF Score
Price $34.05
GF Value $35.48
! 5 Warning Signs
View Full Analysis

What is Kobayashi Pharmaceutical Co Other Current Payables?

Kobayashi Pharmaceutical Co KBYPF -2.71% 81 Other Current Payables is $198 Mil as of Dec. 2025. GuruFocus rates KBYPF with a GF Score™ of 81/100 and a GF Value™ of $35.48. The stock has 5 warning signs investors should review.

Kobayashi Pharmaceutical Co's Other Current Payables for the quarter that ended in Dec. 2025 was $198 Mil.

Kobayashi Pharmaceutical Co's quarterly Other Current Payables declined from Jun. 2025 ($109 Mil) to Sep. 2025 ($95 Mil) but then increased from Sep. 2025 ($95 Mil) to Dec. 2025 ($198 Mil).

Kobayashi Pharmaceutical Co's annual Other Current Payables declined from Dec. 2023 ($174 Mil) to Dec. 2024 ($111 Mil) but then increased from Dec. 2024 ($111 Mil) to Dec. 2025 ($198 Mil).

Kobayashi Pharmaceutical Co Other Current Payables Related Terms

Kobayashi Pharmaceutical Co Other Current Payables Historical Data

* Premium members only.

The historical data trend for Kobayashi Pharmaceutical Co's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kobayashi Pharmaceutical Co Other Current Payables Chart

Kobayashi Pharmaceutical Co Annual Data
Trend Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 186.12 151.27 173.89 111.28 198.29

Kobayashi Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 64.83 109.32 94.53 198.29 101.76
KBYPF
81GF Score
Kobayashi Pharmaceutical Co Ltd KBYPF
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kobayashi Pharmaceutical Co Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of $198 Mil mean?
Kobayashi Pharmaceutical Co (KBYPF) has a Other Current Payables of $198 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Kobayashi Pharmaceutical Co and its competitors.
Is Kobayashi Pharmaceutical Co's Other Current Payables too high?
Kobayashi Pharmaceutical Co's current Other Current Payables is $198 Mil. Overall, Kobayashi Pharmaceutical Co has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Kobayashi Pharmaceutical Co's Other Current Payables compare to PG and CL?
Kobayashi Pharmaceutical Co's Other Current Payables of $198 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Consumer Packaged Goods company?
A good Other Current Payables depends on the Consumer Packaged Goods industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Kobayashi Pharmaceutical Co and its competitors. Kobayashi Pharmaceutical Co's current Other Current Payables is $198 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kobayashi Pharmaceutical Co stock overvalued right now?
Kobayashi Pharmaceutical Co (KBYPF) has a current Other Current Payables of $198 Mil. The stock's GF Value™ is $35.48, compared to a current price of $34.05 — trading 4% below its estimated fair value. The current Other Current Payables is $198 Mil. Kobayashi Pharmaceutical Co's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Kobayashi Pharmaceutical Co (KBYPF), the current Other Current Payables is $198 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kobayashi Pharmaceutical Co (KBYPF) Overvalued in 2026?

Based on GuruFocus' analysis, Kobayashi Pharmaceutical Co stock appears to be undervalued. The current stock price of $34.05 is trading 4% below its estimated GF Value™ of $35.48.

Key valuation signals for KBYPF:

  • Other Current Payables: $198 Mil
  • GF Value™: $35.48 vs. price of $34.05 (4% below fair value)
  • GF Score™: 81/100 with 5 warning signs

No single metric tells the full story. See the KBYPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kobayashi Pharmaceutical Co Business Description

Other Exchanges 4967:Japan
Address 4-4-10 Doshomachi, KDX Kobayashi Doshomachi Building, Chuo-ku, Osaka, JPN, 541-0045
Kobayashi Pharmaceutical Co Ltd is engaged in the manufacture and sale of healthcare products, daily necessities, and body warmers. The company operates through two reportable segments: Domestic Business and International Business, which handle production and sales activities in Japan and overseas, respectively. The company's product portfolio includes disposable body warmers, cooling gel sheets, OTC pharmaceuticals, oral hygiene products, air fresheners, eyeglass wipes, and deodorizing/household sundries.
81GF Score

Get the complete analysis for KBYPF

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$34.05
Price
$35.48
GF Value